Heron Therapeutics
- Pharmaceutical Preparations
- San Diego, California
Compensation history
Top executives at Heron Therapeutics received an average of $2M per person in annual compensation from 2006 to 2023.
Average pay of disclosed executives at Heron Therapeutics
By year
Executives
We found 23 executives who work or worked at Heron Therapeutics.
Craig Collard
Heron Therapeutics
Chief Executive Officer
Ira Duarte
Heron Therapeutics
Chief Financial Officer
William Forbes
Heron Therapeutics
Chief Development Officer
Barry Quart
Heron Therapeutics
Chief Executive Officer
David Szekeres
Heron Therapeutics
Executive Vice President, Chief Commercial Officer
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
News
Heron Therapeutics CEO Craig Collard receives $11M in 2023
April 29, 2024
Heron Therapeutics Executive Vice President, Drug Development Kimberly Manhard's 2022 pay falls 22% to $1.4M
May 1, 2023
Heron Therapeutics CEO Barry Quart's 2021 pay rises 2% to $5.4M
April 25, 2022
Heron Therapeutics CEO Barry Quart's 2020 pay slips 9% to $5.3M
April 22, 2021
Heron Therapeutics CEO Barry Quart's 2019 pay slips 2% to $5.9M
April 23, 2020
About Heron Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address4242 Campus Point Court, Suite 200, San Diego, California 92121
- Phone8582514400
- Fiscal year endDecember 31
- Former names
- AP PHARMA INC /DE/Until January 6, 2014
- ADVANCED POLYMER SYSTEMS INC /DE/Until April 5, 2001
Source: SEC filings on April 29, 2024, May 1, 2023, April 25, 2022, April 22, 2021, April 23, 2020, April 29, 2016, May 9, 2013, June 3, 2011, April 23, 2010, April 20, 2009, and April 14, 2008.